ESC 365 - Rivaroxaban treatment prevents atrial myocyte hypertrophy in goats with persistent atrial fibrillation by inhibition of protease activated receptor 1

EHRA Premium Access

Rivaroxaban treatment prevents atrial myocyte hypertrophy in goats with persistent atrial fibrillation by inhibition of protease activated receptor 1

Session: Young Investigator Award Basic and Translational Science

Topic: Cellular Mechanisms of Arrhythmias

Speaker: Doctor E. D'Alessandro (Maastricht, NL)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Elisa D'Alessandro

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

0 follower

3 more presentations in this session

Targeting CCR2+ macrophages and SPP1 in HFpEF: the promise of vagus nerve stimulation

Speaker: Doctor M. Toumpourleka (Oklahoma City, US)

Decoding atrial mechanics: human atrial slices as a model for atrial disease

Speaker: Ms E. Van Doorn (Erasmus Medical Centre - Rotterdam, NL)

Impact of catheter type on lesion dimensions in focal-bipolar pulsed field ablation

Speaker: Doctor L. Zarebski (Rzeszow, PL)

Access the full session

Young Investigator Award Basic and Translational Science

Speakers: Doctor E. D'Alessandro, Doctor M. Toumpourleka, Ms E. Van Doorn, Doctor L. Zarebski

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources